Labiana Health (XMAD:LAB) Equity-to-Asset : 0.12 (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Labiana Health's Total Stockholders Equity for the quarter that ended in Dec. 2022 was €7.04 Mil. Labiana Health's Total Assets for the quarter that ended in Dec. 2022 was €60.78 Mil. Therefore, Labiana Health's Equity to Asset Ratio for the quarter that ended in Dec. 2022 was 0.12.

The historical rank and industry rank for Labiana Health's Equity-to-Asset or its related term are showing as below:

XMAD:LAB's Equity-to-Asset is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Labiana Health Equity-to-Asset Historical Data

The historical data trend for Labiana Health's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Equity-to-Asset Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Equity-to-Asset

0.22

0.17

0.12

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Equity-to-Asset	0.22	0.17	0.20	0.12

Competitive Comparison of Labiana Health's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Labiana Health's Equity-to-Asset falls into.

Labiana Health Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Labiana Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	7.035	/	60.779
	=	0.12

Labiana Health's Equity to Asset Ratio for the quarter that ended in Dec. 2022 is calculated as

Equity to Asset (Q: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	7.035	/	60.779
	=	0.12

Labiana Health (XMAD:LAB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Labiana Health Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Labiana Health's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Equity-to-Asset

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.